Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.9157
+0.0055 (0.60%)
At close: Aug 6, 2025, 4:00 PM
0.9101
-0.0056 (-0.61%)
After-hours: Aug 6, 2025, 7:59 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $106.16 million as of August 6, 2025. Its market cap has decreased by -45.56% in one year.
Market Cap
106.16M
Enterprise Value
323.25M
1-Year Change
-45.56%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $106.16M, a decrease of -73.74%. That is a compound annual growth rate of -11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 106.20M | -33.21% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |